Immune Design CS
(IMDZ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,975 | -10,569 | -6,575 | -2,941 | -10,840 |
| Depreciation Amortization | 407 | 315 | 221 | 126 | 540 |
| Accounts receivable | 426 | 310 | -432 | 55 | N/A |
| Accounts payable and accrued liabilities | -213 | -112 | -21 | -529 | N/A |
| Other Working Capital | -34 | -84 | -1,562 | -1,062 | 440 |
| Other Operating Activity | 1,091 | -102 | 505 | 491 | 290 |
| Operating Cash Flow | $-14,298 | $-10,242 | $-7,864 | $-3,860 | $-9,570 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -132 | -95 | -76 | -68 | -290 |
| Investing Cash Flow | $-132 | $-95 | $-76 | $-68 | $-290 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6 | 6 | 6 | 6 | N/A |
| Other Financing Activity | 32,049 | 0 | 0 | 0 | 10,620 |
| Financing Cash Flow | $32,055 | $6 | $6 | $6 | $10,620 |
| Beginning Cash Position | 12,762 | 12,762 | 12,762 | 12,762 | 12,000 |
| End Cash Position | 30,387 | 2,431 | 4,828 | 8,840 | 12,760 |
| Net Cash Flow | $17,625 | $-10,331 | $-7,934 | $-3,922 | $750 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,298 | -10,242 | -7,864 | -3,860 | -9,570 |
| Capital Expenditure | -175 | -138 | -119 | -108 | N/A |
| Free Cash Flow | -14,473 | -10,380 | -7,983 | -3,968 | -9,570 |